Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13D/A for ESSA Pharma Inc. Common Shares (EPIX).
- Disclosed ownership: 25%.
- Date of event: 05 Aug 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 25% ownership in ESSA Pharma Inc. Common Shares (EPIX) on 05 Aug 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 13% | 6,194,145 | 0 | 6,194,145 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0000918923 |
| BVF I GP LLC | 13% | 6,194,145 | 0 | 6,194,145 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001803805 |
| BIOTECHNOLOGY VALUE FUND II LP | 10% | 4,726,743 | 0 | 4,726,743 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001102444 |
| BVF II GP LLC | 10% | 4,726,743 | 0 | 4,726,743 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001803806 |
| Biotechnology Value Trading Fund OS LP | 1.2% | 560,797 | 0 | 560,797 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001660683 |
| BVF Partners OS Ltd. | 1.2% | 560,797 | 0 | 560,797 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001660684 |
| BVF GP HOLDINGS LLC | 23% | 10,920,888 | 0 | 10,920,888 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001803809 |
| BVF PARTNERS L P/IL | 25% | 11,668,473 | 0 | 11,668,473 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001055947 |
| BVF INC/IL | 25% | 11,668,473 | 0 | 11,668,473 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001056807 |
| LAMPERT MARK N | 25% | 11,668,473 | 0 | 11,668,473 | /s/ Mark N. Lampert | Mark N. Lampert | 0001233840 |